Cross Country Healthcare CAO reports tax share withholding

CROSS COUNTRY HEALTHCARE INC Chief Accounting Officer Marvin Veizaga reported a Form 4 transaction involving company common stock.

Rhea-AI Filing Summary

CROSS COUNTRY HEALTHCARE INC Chief Accounting Officer Marvin Veizaga reported a Form 4 transaction involving company common stock. On July 9, 2026, 236 shares were disposed of through share withholding to satisfy tax obligations arising from restricted stock vesting, rather than an open-market sale. Following this tax-withholding disposition, Veizaga holds 31,480 shares of common stock directly.

Insights

Equity Compensation Analyst

Routine tax share withholding tied to vesting; no open-market sale.

Chief Accounting Officer Marvin Veizaga had 236 shares of CROSS COUNTRY HEALTHCARE INC common stock withheld on July 9, 2026 at $13.21 per share. The footnote explains this satisfied tax withholding obligations for restricted stock that vested the same day.

This is a standard equity-compensation mechanism, coded as a tax-withholding disposition, not a discretionary market trade. After the withholding, Veizaga directly owns 31,480 shares, indicating a continuing equity stake. The filing does not reference any Rule 10b5-1 trading plan or additional derivative positions.

Insider Trade Summary

Tax Withholding: 236 shares

Tax Withholding 1 txn

Insider Veizaga Marvin

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	236	$13.21	$3K

Holdings After Transaction: Common Stock — 31,480 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on July 9, 2026.

Key Figures

Shares withheld for taxes: 236 shares Transaction price per share: $13.21 Shares owned after transaction: 31,480 shares +1 more

4 metrics

Shares withheld for taxes 236 shares Common stock withheld on July 9, 2026 to satisfy tax obligations

Transaction price per share $13.21 Value per CCRN share in the July 9, 2026 tax-withholding disposition

Shares owned after transaction 31,480 shares Direct common stock holdings of Marvin Veizaga following the transaction

Tax withholding shares in summary 236 shares Reported as taxWithholdingShares in transaction summary

Key Terms

tax withholding obligations, restricted stock, tax-withholding disposition

3 terms

tax withholding obligations financial

"These shares were withheld to satisfy tax withholding obligations for restricted stock"

restricted stock financial

"tax withholding obligations for restricted stock which vested on July 9, 2026"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CROSS COUNTRY HEALTHCARE INC (CCRN) report for Marvin Veizaga?

CROSS COUNTRY HEALTHCARE INC reported that Chief Accounting Officer Marvin Veizaga had 236 common shares withheld on July 9, 2026. The shares were used to cover tax obligations from vesting restricted stock, not sold in the open market.

Was the CCRN Form 4 transaction by Marvin Veizaga an open-market sale of shares?

No, the Form 4 for CCRN shows a tax-withholding disposition, not an open-market sale. 236 shares were withheld to satisfy tax liabilities related to restricted stock vesting on July 9, 2026.

How many CROSS COUNTRY HEALTHCARE INC (CCRN) shares were withheld for taxes from Marvin Veizaga?

The filing reports that 236 CCRN common shares were withheld. These shares covered tax withholding obligations tied to restricted stock that vested on July 9, 2026, according to the Form 4 footnote.

What is Marvin Veizaga’s CCRN share ownership after the reported Form 4 transaction?

After the July 9, 2026 tax-withholding disposition, Chief Accounting Officer Marvin Veizaga directly owns 31,480 shares of CROSS COUNTRY HEALTHCARE INC common stock, as disclosed in the Form 4 filing.

At what price were the CCRN shares valued in Marvin Veizaga’s tax-withholding transaction?

The 236 CROSS COUNTRY HEALTHCARE INC shares withheld for taxes were valued at $13.21 per share. This price is disclosed as the transaction price per share in the Form 4 report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/10/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Veizaga Marvin

(Last) (First) (Middle)

C/O CROSS COUNTRY HEALTHCARE, INC.

5201 CONGRESS AVENUE, SUITE 160

(Street)

BOCA RATON FLORIDA 33487

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CROSS COUNTRY HEALTHCARE INC [ CCRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/09/2026		F		236(1)	D	$13.21	31,480	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld to satisfy tax withholding obligations for restricted stock which vested on July 9, 2026.

	/s/ Marvin Veizaga	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)